Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1

Annals of Clinical and Laboratory Science

Volumn 28, Issue 6, 1998, Pages 315-323

  Masood, Shahla ^a,b   Bui, Marilyn M ^a   Lu, Leo ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b Kls Martin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; BREAST CARCINOMA; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ANEUPLOIDY; ANTIGENS, NUCLEAR; AUTOANTIGENS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; DIPLOIDY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NUCLEAR PROTEINS; ROC CURVE; S PHASE;

EID: 0031772331     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. NIH Consensus Conference: Treatment of early stage breast cancer. JAMA 1991;265:395.
2. Early Breast Cancer Trialists' Collaborative Group: Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer: An Overview of 61 Randomized Trials among 28,896 Women. N Engl J Med 1988;319:1681.
3. Bonadonna G, Valagussa P, Tancini G, et al. Current Status of Milan Adjuvant Chemotherapy Trials for Node-Positive and Node-Negative Breast Cancer. NCI Monogr 1986;1:45.
4. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trials evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479.
5. Fisher B, Redmond C, Dimitrov NY, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor negative tumors. N Engl J Med 1989;320: 473.
6. Mansour FG, Gay R, Shatila AH, et al: Efficiency of adjuvant chemotherapy in high-risk node negative breast cancer. An intergroup study. N Engl J Med 1989;320:485.
7. Bonadonna G. Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer. J Clin Oncol 1989;7:1380-1397.
8. Salmon SE (Ed.): Adjuvant therapy of cancer. Volume 6, Saunders, Philadelphia, PA, 1990.
9. NIH Consensus Conference: Treatment of Early Stage Breast Cancer. JAMA 1991;265:391-395.
10. Masood S: Prognostic Factors in breast cancer. J Surg Pathol 1995;1:45-61.
11. Masood S. Prediction of recurrence for advanced breast cancer: traditional and contemporary pathologic and molecular works. In: The Surgical Oncology Clinics of North America, ed. Bland KJ, WB Saunders Company. Philadelphia, 1995;601-632.
12. Johnson H Jr, Masood S, Belluco C, et al. Prognostic factors in node-negative breast cancer. Arch Surg 1992;127:1386.
13. Wintzer H-O, Sipfel I, Schulte-Monting J, Hellerich U, von Kleist S: Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-428.
14. Brown RW, Allred DC, Clark GM, Tandon AK, McGuire WL: The prognostic significance of cell-cycle kinetics measured by Ki-67 immunohistochemistry in node-negative breast cancer. Lab Invest 1991; 64:10A (abstr).
15. Shahin AA, Ro J, Ro JY, Blick MB, El-Naggar AK, Ordonez NG, et al: Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 1991;68:549-557.
16. Coon JS, Weinstein RS. Diagnostic Flow Cytometry, 1st ed., Williams & Wilkins, Baltimore, 1991:131-132.
17. Hedley DW, Friedlander ML, Taylor JW, Rugg CA, and Musgrove EA. Method for Analysis of Cellular DNA Content of Paraffin-embedded Pathological Material Using Flow Cytometry. J. Histochem Cytochem 1983;31:1333.
18. MacGrogan G, Jollet I, Huet S, Sierankowski G, Picot V, Bonichon F, and Coindre JM: Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma. Mod Pathol 1997;10(8):769-76.
19. Dalquen P, Baschiera B, Chaffard R, Dieterich H, Feichter GE, Krmer K, and Torhorst J: MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears. Acta Cytol 1997;41(2):229-37.